from lab to market - home - nstda

20
From LAB to Market: A Challenge For Healthcare In Thailand and Global Prof. Dr. Pairash Thajchayapong President, BCG Medical Devices

Upload: others

Post on 10-Jun-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: From LAB to Market - Home - NSTDA

From LAB to Market:A Challenge For Healthcare In Thailand and Global

Prof. Dr. Pairash ThajchayapongPresident, BCG Medical Devices

Page 2: From LAB to Market - Home - NSTDA

�������������� ������������

2

Single-used devices(ex. Syringes, gloves, mask, suction catheters, surgical sponges and implants)

Durable medical devices(ex. Hospital beds, Wheel chair, Electro mechanical medical devices, Infusion pumps, X-ray, Active devices)

Reagents and test kits(ex. Covid-19 screening test, Blood group testing, HIV rapid test, Pregnancy test)

Page 3: From LAB to Market - Home - NSTDA

Thailand: A Hub of Wellness and Medical Services

Source : Malaysia Healthcare Travel Council and Singapore Tourism board

Thailand

Estimated earnings

Number of foreign patients

4.5 billion2.5 billion

Singapore Malaysia

Estimated earnings

Number of foreign patients850,000

Estimated earnings

Number of foreign patients

158 million

583,000

Thailand is MOST PREPARED to tackle a Global Pandemic (1st Asia and 6th Global) Thailand ranks 2nd World best country for recovering from COVID-19 epidemic

(global Covid-19 index)

4th World-class Medical Facilities across the Country ( > 67 JCI-accredited healthcare providers)

6th Global Health Security Index 2019

16th Attractiveness of a country as a medical tourist destination (MTI index)

3.5 billion

3

ref : 1.https://www.gsbresearch.or.th/(2562) 2.Towards becoming No.1 Medical Hub of Asia (2560) , BOI 3. https://covid19.pemandu.org/#rank

Page 4: From LAB to Market - Home - NSTDA

Thailand: A Hub of Wellness and Medical Services

Import Export

4

ref : https://2016.export.gov/industry/health/healthcareresourceguide/eg_main_108623.asp

Total healthcare expenditure in Thailand amounts to approximately $25.3 billion, and are expected to increase to $47.9 billion by 2026

Total expenditure on medical devices between 2016-2019 is over $2 billion/year

Thailand’s outbound shipment of medical devices grew from US$ 554 million in 2011 to US$ 843 million in 2018

The value of imports grew from US$ 557 million to US$ 962 million, over the same period.

Thailand’s top medical device imports are in vitro diagnostic devices, ophthalmic devices, optical devices, and hospital hardware, etc.

US$

1200

1000

800

600

400

200

0

Import Export

557 554

843

962

Page 5: From LAB to Market - Home - NSTDA

Major Domestic Medical Device Manufacturers

Number by size

Source: Business Online, compiled by Krungsri ResearchNote: * data as of 31 March 2018 **data as of 30 June 2018

Company Major shareholders

Revenue2017

(THB,m)

Nipro (Thailand) Japanese 7,534.7

Hoya Optics (Thailand)* Dutch 5,959.3

Asahi Intecc (Thailand)** Japanese 3,890.9

Kawasumi Laboratories (Thailand)* Japanese 2,444.6

Reckitt Benckiser Healthcare Thai 1,940.6Manufacturing (Thailand)

Eyebiz Laboratory (Thailand) Australian 1,375.6

Emerald Nonwovens International Chinese 1,298.0

M.E.Nikkiso Japanese 935.9

Greiner Bio-One (Thailand) Australian 783.5

Infus Medical (Thailand) Thai 764.8

Revenue by size(2017)

Large65% Small

Medium20%

Medium4%Me4%

Large2%

Medium20%

Small94%

ReReReReveveveenununuueeee20201717

(THB,m)

7,534.7

5,959.3

3,890.9

2,444.6

1,940.6

1,375.6

1,298.0

935.9

783.5

764.8

5

Medical devices Industry : investment climate in THAILAND

There are around 600 domestic medical device manufacturers in Thailand 98% are small and medium enterprises

Large enterprises have revenue around 65% of total revenue. (US$ 870 million)

Source : Business Online, compiled by Krungsri Research

Page 6: From LAB to Market - Home - NSTDA

6

Implant & Medical Supplies

Digital Platform

Medical Equipment

TeleMed/Telehealth

AI IOTs/Wearable devices

CT

Medical Robots

Digital X-ray

Hearing aids

N95Rehab. equipment

Assistive Devices

N95

3D Print model

Knee Implant

sPPE

Stent

Dental Implant Bone graft

Current Challenge : Empower Domestic Medical devices SMEs competitiveness

Support Thailand’s rise as world medical hub and center for the export of medical devices to the ASEAN countries

Increase national healthcare security and competitiveness

Increase equality among Thai citizen in national health care services

Page 7: From LAB to Market - Home - NSTDA

���������������� � ���!"�#�%&�'*�+;���<�=>�?@JK�JNKO> ��Q��Y�OJZN�OZ[<?K\

7

Strategy: Lab to Market Using Government as a

Strategy 1 Analyze national supply-demand database and identify targeted products

Strategy 2 Use government as an initial market

Strategy 3 Provide incentives to empowering the domestic investment

Strategy 4 Develop high-skilled human resources & SMEs

Strategy 5 Establish win-win platform & partnership model

Increase medical devices procurement from Thai Innovation List to 30% of total government’s medical device expenses/yearCreate economic and social impact 1 billion US dollars within 5 yearsEnable the sustainable growth of Thai medical device industry

Single-use device Durable devices Reagents and test kits

Goals

Page 8: From LAB to Market - Home - NSTDA

Strategy 1 Analyze national supply-demand and identify market oriented products

8

Imported Medical Device By Type ( Million THB) Example ����������� ��������������������

(NHSO) covers about 48 million people in Thailand include health care services given to chronic kidney failure at a budget of approx. 9.5 billion baht in 2019.

In a NSHO pilot scheme, patients with renal diseases (>30,000 cases) would also be given access to

Automated Peritoneal Dialysis(APD) treatment requiring both devices and reagent.

NB: 1.Total expenditure on medical devices between 2016-2019 is over $2 billion/year 2. 1 US$ = 32 THB

ref: 1. global trade atlas 2. https://www.nationthailand.com/news/30319801 3. https://2016.export.gov/industry/health/healthcareresource guide/eg_main_108623.asp

2010 2011 2012 %GrowthGeneral supply 9,407 11,363 14,555 24%

Opnthalmology 7,704 8,236 8,630 24%

Diagnostic and Therapeutic 8,075 10,051 11,327 18%equipment for internal medicine

Dental 1,947 2,525 2,535 14%

Surgery 1,947 721 835 -35%

Laboratory 792 851 1059 16%

Orthopedic, orthosis and 1,890 2,053 2,415 13%disability aidsMedical Logistic and patient ward 412 709 785 38%

Diagnostic imaging and 3,751 4,067 6,180 28% raiotheraphy

General equipment 597 787 1,086 35%

Total 36,522 41,363 49,407 16%

Page 9: From LAB to Market - Home - NSTDA

9

Strategy 2 Use government as a initial market

����������� ��

Stage 1 Stage 2 Stage 3 Stage 4

1. Government making list of targeted devices.2. Government R&D funding agencies in collaboration with companies provide funds to produce the targeted device prototypes with approved standard and quality.3. Market trial period using the sandbox concept.4. Government procurement via the Thai Innovation List.

Feasibilitytest

Medical Standard��������� � ����

���� �����Med. devices

���� �Mass

�� ���� �

������

� ������� � ���

������ ���� �• Multi-clinical trial • User feedback evaluation

� ���������� �����������!"����� ���� �#���

!��"� � $�# ����'��� �

30% $ vernment �r curement

���� �

Page 10: From LAB to Market - Home - NSTDA

10

What is Thai Innovative List?

�����$*+/;<*+*+=�"������>?@@���� J�� ������>;@KO**Q�����V�������� ����

Since 2015, the “Thai Innovative List” is a government policy to promote Thai innovation. Products or services innovated locally, passed the national and international safety standards, and approved competitive prices are listed in the Thai Innovative List.Government agencies can purchase these listed products and services by a special method such as direct buying without bidding.The minimum amount of procurement is 30% per year.

Page 11: From LAB to Market - Home - NSTDA

Strategy 3 : Provide incentives to empowering the domesticinvestment (R&D+manufacturing)

NB: ARIPOLOIS = Innovation center for Automation Robotics and Intelligent System BIOPOLIS = Innovation center for Biotechnology

!"�����X ��YJ����������OXY�V provides incentives for foreign investors to set up new bases or form joint ventures with local partners to manufacture medical devices, through 3-8 years tax exemption policy for domestic R&D and manufacturing.

��������� � ���Z ��� � J��� ���� �O��Z�V establishes a technology and infrastructure �������������������������!��"������#����!��"���$'+��������������������������������medical system at global level and (2) enable the country to become the exporter of the medical-related products and (3) reach the country’s goal of becoming the international medical hub

!"��Z��� ������������ is aiming to assist domestic assemblers and manufacturers with tax free for imported high-quality parts and components (from 30% to 0%)

11

Page 12: From LAB to Market - Home - NSTDA

/*

Page 13: From LAB to Market - Home - NSTDA

13Ref: https://www.nstda.or.th/en/news

September 2019, EECi and[�"� �\��������� entered into a [�� ����� J]$������� to develop a master plan for the development of medical device industry in the Eastern Economic Corridor of Innovation (EECi) to generate an “innovation ecosystem” as mechanism to entice technology utilization and commercialization

Medical devices industry technology roadmap“Innovation ecosystem”

Page 14: From LAB to Market - Home - NSTDA

14

Thai Customs Department is aiming to assist domestic assemblers and manufacturers with tax free for imported high-quality parts and components

ref : http://itd.customs.go.th/igtf/th/main_frame.jsp?lang=th&top_menu=menu_homepage&current_id=5028

Page 15: From LAB to Market - Home - NSTDA

Strategy 4 : Develop high-skilled Human resources & SMEs

/;

!"�[������� ����Z �� ����� J!"�����O[�Z!VO �$���'���!"��^�]����������V

_`{|}~�}�~{|���{�������~{��Z�����J �^�����]�����

�������� �������� ���������������������������"� �$"�� J���� ����������$�� $��������������

Seminar : Essential Regulatory Requirements for Medical Device Approval!������$�� $����• International guideline : GMP/ ISO13485 /EN ISO13485:2016/ AMDD /Common Submission � ;��������������$<�;�+�=<?�@��F�Q�V����YV• Good Clinical Practices Guidelines• PDPA (Personal Data Protection Act)• CybersecurityZ���F�����Q������

Page 16: From LAB to Market - Home - NSTDA

/Q

������$�;���������"���<�������J �����������"��� ��O���� ������V

#����Q���Q[����V�\�[\�������������]������\�F�������������\������������F�������?��������������\�F����������Q�\��Q�������Engaging in End-to-End Customer Experience

Imaging Modality

Digital X-ray

DentiScan MobiiScan

Implant

CraniofacialImplant

DentalImplant Orthopedic

Implant

CardiovascularImplant

• Coronary stent• 3D printed implant

Cloud-management system/ Implant Planning

Z������������������������Z����������������������• Humerus endoprosthesis• Knee Implant

Z� �=�<�• HA with BMP2• Collagen Sheet• MIM/CIM Dental Implant

• Zirconia crown bridge/RPD/Surgical guide (Implant related)

Page 17: From LAB to Market - Home - NSTDA

��$�����������������J ��

Improve Accessibility

Reduce Inequality

• More than 2 million people will have access to affordable dental implant services• More skilled dentists in rural area via training in our platform

X���Z �������������

• New medical device manufacturers and dental service businesses with expected• New S-curve industry development (Medical device industry)

����������� ����;+� �������

������� J#�J�

��$�����������������J ��

�������������

Enhance Dental Services

Build New Industry& Endorse

“Innovation List”

DentiiScan

17

Page 18: From LAB to Market - Home - NSTDA

i-CREATe : international Convention on Rehabilitation Engineering andAssistive Technology under HRH Princess Maha Chakri Sirindhorn’s Initiatives

International platform of conference, Global Student Innovation Challenge(gSIC), and exhibition featuring innovative technology, equipment, applications, ����������� ���������������� ����������� ����Assistive & Rehabilitative Technology Technical exchanges to share ideas and best practices������� ������������� �����������������������10 Members (Singapore, Thailand, Malaysia, China, Taiwan, Hong Kong, South Korea, Japan, New Zealand and Australia)

^� �]������� X��������������Z��<���������

/�Z[��[������ �����

*��Y�]� �����Spacewalker 18

Hoist, standingwheel chair

Page 19: From LAB to Market - Home - NSTDA

ASEAN community as a Medical devices “MARKETS”

�����$�"��]��]�[��������������������"� ���� ���� ���

joining regional platform activities such as iCREATe

multi-national SMEs technology localization model

ASEAN government as regional market

Etc.

19

Page 20: From LAB to Market - Home - NSTDA

Conclusions

ref.: The “valley of death.” Orin Herskowitz, ColumbiaUniversity, presentation to the symposium, April 6, 2016

]� ���������������$���� ��� �$���� � ����� ��� ���������� �����������

!"������$��������������������"���������������� ���� �"����J����$� ���� J�"�$ ���������

]����$� �= Can ASEAN be one of the world’s best wellness and medical service hub? Can ASEAN be one of the world’s top medical device manufacturing hub? Can ASEAN be the “Silicon Valley” of medical device innovation?

!"������� J���"

*+